Comments
Loading...
National Health Investors Stock Guidance | NYSE:NHI | Benzinga
National Health Investors issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/25/2025 | NHI | National Health Investors | FY | 2025 | $4.59 | $4.66 | $4.69 | — | — | — | Get Alert |
| 11/05/2024 | NHI | National Health Investors | FY | 2024 | $4.43 | $4.44 | $4.50 | — | — | — | Get Alert |
| 08/06/2024 | NHI | National Health Investors | FY | 2024 | $4.52 | $4.56 | $4.40 | — | — | — | Get Alert |
| 05/06/2024 | NHI | National Health Investors | FY | 2024 | $4.37 | $4.43 | $4.35 | — | — | — | Get Alert |
| 02/20/2024 | NHI | National Health Investors | FY | 2024 | $4.31 | $4.37 | $4.33 | — | — | — | Get Alert |
| 11/07/2023 | NHI | National Health Investors | FY | 2023 | $4.28 | $4.31 | $4.34 | — | — | — | Get Alert |
| 08/08/2023 | NHI | National Health Investors | FY | 2023 | $4.31 | $4.35 | $4.40 | — | — | — | Get Alert |
| 05/09/2023 | NHI | National Health Investors | FY | 2023 | $4.37 | $4.42 | $4.27 | — | — | — | Get Alert |
| 02/21/2023 | NHI | National Health Investors | FY | 2023 | $4.24 | $4.30 | — | — | — | — | Get Alert |
| 11/08/2022 | NHI | National Health Investors | FY | 2022 | $3.86 | $3.92 | — | — | — | — | Get Alert |
| 08/08/2022 | NHI | National Health Investors | FY | 2022 | $3.86 | $3.92 | — | — | — | — | Get Alert |
| 06/06/2022 | NHI | National Health Investors | FY | 2022 | $4.32 | $4.42 | — | — | — | — | Get Alert |
| 05/09/2022 | NHI | National Health Investors | FY | 2022 | $4.32 | $4.42 | — | — | — | — | Get Alert |
| 04/18/2022 | NHI | National Health Investors | FY | 2022 | $4.32 | $4.42 | — | — | — | — | Get Alert |
FAQ
What is the most recent guidance for National Health Investors (NHI)?
The most recent guidance for National Health Investors (NHI) was reported on February 25, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $4.59 to $4.66, compared to the estimated EPS of $4.69. Additionally, National Health Investors forecasted revenue between $0.00B and $0.00B for the quarter.
Browse guidance and forecast on all stocks.